Table 3: Complications as observed groupwise.

ComplicationsGroup AGroup B

UTI1 (5%)2 (10%)
Postvoid dribbling4 (20%)4 (20%)
Urethro cutaneous fistula01 (5%)
Erectile dysfunction3 (15%)2 (10%)
Donor site complications1 (5%)1 (5%)
Recurrence 2 (10%)1 (5%)
Wound infection1 (5%)1 (5%)